Tempest to Participate in the Piper Sandler 36th Annual Healthcare Conference

Rhea-AI Summary

Tempest Therapeutics (Nasdaq: TPST), a clinical-stage biotech company focused on developing first-in-class targeted and immune-mediated cancer therapeutics, has announced its participation in the Piper Sandler 36th Annual Healthcare Conference. The company's senior management will engage in a fireside chat on Tuesday, December 3, 2024 at 9:00 a.m. ET. Interested parties can access both live and archived recordings of the discussion through the investor section of Tempest's website at ir.tempesttx.com.

News Market Reaction – TPST

+2.75%

+2.75% Session move

In the trading session that priced this news, TPST gained 2.75%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BRISBANE, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classⁱ targeted and immune-mediated therapeutics to fight cancer, today announced that members of senior management will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024 at 9:00 a.m. ET.

To access the live or archived recording of the discussion, please visit the investor section of the Tempest website at https://ir.tempesttx.com.

About Tempest Therapeutics
Tempest Therapeutics is a clinical-stage biotechnology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. Tempest is headquartered in Brisbane, California. More information about Tempest can be found on the company’s website at www.tempesttx.com.

Investor Contacts:

Sylvia Wheeler
Wheelhouse Life Science Advisors
swheeler@wheelhouselsa.com

Aljanae Reynolds
Wheelhouse Life Science Advisors
areynolds@wheelhouselsa.com

^{_______________________________ 
i} If approved by the FDA

FAQ

When is Tempest Therapeutics (TPST) presenting at the Piper Sandler Healthcare Conference 2024?

Tempest Therapeutics (TPST) will present at the Piper Sandler Healthcare Conference on Tuesday, December 3, 2024, at 9:00 a.m. ET.

How can investors access Tempest Therapeutics' (TPST) Piper Sandler Conference presentation?

Investors can access both the live and archived recordings of Tempest Therapeutics' presentation through the investor section of their website at ir.tempesttx.com.

What type of presentation will TPST give at the Piper Sandler Healthcare Conference 2024?

TPST's senior management will participate in a fireside chat format presentation at the conference.

What is the focus of Tempest Therapeutics' (TPST) drug development program?

Tempest Therapeutics focuses on developing first-in-class targeted and immune-mediated therapeutics for fighting cancer.